BHVN - Biohaven Pharmaceutical Holding Company Ltd.

NYSE - NYSE Delayed price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Jun 2020)Next qtr. (Sep 2020)Current year (2020)Next year (2021)
No. of analysts991010
Avg. Estimate-2.61-2.27-10.19-5.72
Low estimate-4.05-2.66-11.35-9.22
High estimate-1.42-1.36-7.22.94
Year ago EPS-4.67-2.04-10.91-10.19
Revenue estimateCurrent qtr. (Jun 2020)Next qtr. (Sep 2020)Current year (2020)Next year (2021)
No. of analysts991010
Avg. Estimate7.65M15.88M52.52M283.73M
Low estimate2.9M8.85M28.54M195M
High estimate12.7M22.2M74.17M545.32M
Year ago salesN/AN/AN/A52.52M
Sales growth (year/est)N/AN/AN/A440.20%
Earnings history29/06/201929/09/201930/12/201930/03/2020
Est. EPS-1.92-1.57-1.87-2.34
Actual EPS-4.67-2.04-2.85-3.07
Difference-2.75-0.47-0.98-0.73
Surprise %-143.20%-29.90%-52.40%-31.20%
EPS trendCurrent qtr. (Jun 2020)Next qtr. (Sep 2020)Current year (2020)Next year (2021)
Current estimate-2.61-2.27-10.19-5.72
7 days ago-2.6-2.24-10.15-5.74
30 days ago-2.54-2.22-10.01-5.73
60 days ago-2.53-2.23-10.1-7
90 days ago-2.3-2.05-8.6-5.97
EPS revisionsCurrent qtr. (Jun 2020)Next qtr. (Sep 2020)Current year (2020)Next year (2021)
Up last 7 days1111
Up last 30 days2222
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesBHVNIndustrySector(s)S&P 500
Current qtr.44.10%N/AN/AN/A
Next qtr.-11.30%N/AN/AN/A
Current year6.60%N/AN/AN/A
Next year43.90%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A